糖尿病合并代谢综合征患者干预六年慢性并发症的发生风险研究

来源 :中国全科医学 | 被引量 : 0次 | 上传用户:objzobjz3
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:了解糖尿病合并代谢综合征(MS)患者干预6年慢性并发症的发生情况,并探讨 MS 对慢性并发症发生风险的影响。方法选取2008年8月北京劲松社区卫生服务中心就诊的2型糖尿病(T2DM)患者441例,根据是否合并 MS 将患者分为糖尿病合并 MS 组(n =290)和糖尿病组(n =151)。所有患者进行干预随访,每6个月详细记录 BMI、腰围、臀围、腰臀比、颈围、收缩压( SBP)、舒张压( DBP)、空腹血糖( FPG)、餐后2 h 血糖(2 hPG)、糖化血红蛋白(HbA1c )、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、尿素氮、肌酐、血尿酸,每年记录大血管、微血管并发症发生情况,随访时间为6年。慢性并发症发生的危险因素分析采用 Cox 回归分析。结果(1)糖尿病合并 MS 组慢性并发症总体发生率(17.6%,51/290)高于糖尿病组(9.3%,14/151),差异有统计学意义(P <0.05);两组 Kaplan _ Meier 生存曲线间差异有统计学意义(χ2=4.82,P =0.028)。(2)Cox 回归分析结果显示,糖尿病合并 MS 患者发生慢性并发症的风险是不合并 MS 患者的1.88倍〔95% CI(1.06,3.85),P =0.031〕;调整性别、年龄、受教育程度后,合并 MS 患者发生慢性并发症的风险是不合并 MS 患者的2.24倍〔95% CI(1.24,4.04),P =0.047〕。(3)糖尿病合并 MS 组干预前 BMI、腰围、臀围、腰臀比、颈围、SBP、DBP、FPG、2 hPG、HbA1c、TG、LDL-C、血尿酸均高于糖尿病组,差异有统计学意义( P <0.05);干预后 BMI、腰围、臀围、腰臀比、颈围、FPG、2 hPG、HbA1c 仍高于糖尿病组,差异有统计学意义( P <0.05)。结论糖尿病合并 MS 患者干预后慢性并发症发生率明显高于不合并 MS 患者,合并 MS 增加了糖尿病患者发生心脑血管疾病的风险。“,”Objective To investigate the occurrence of chronic complications of diabetic patients with metabolic syndrome(MS)after 6 _ year intervention and the influence of MS on the risk of chronic complications. Methods In August 2008,we enrolled 441 T2DM patients who received treatment in Jinsong Community Health Service Center. According to whether patients were complicated with MS,the patients were divided into diabetic with MS group( n = 290)and diabetic group( n= 151). Intervention follow _ up was conducted on all patients,and BMI,waistline,hipline,waist _ hip ratio,neck circumference,SBP,DBP,FPG,2 hPG,HbA1c ,TG,TC,HDL-C,LDL-C,urea nitrogen,creatinine and blood uric acid were recorded every six months. The occurrence rates of great vessel and microvascular complications were recorded each year. And the follow _ up lasted for 6 years. The risk factors for the occurrence of chronic complications were analyzed by Cox regression analysis. Results (1)The incidence of chronic complications of diabetic with MS group was higher than that of diabetic group 〔(17. 6% ,51 / 290)vs. (9. 3% ,14 / 151)〕 (P < 0. 05);the two groups were significantly different in Kaplan _ Meier survival curve( χ2 = 4. 82,P = 0. 028 ) . ( 2 ) The results of Cox regression analysis showed that the risk of chronic complications in diabetic patients complicated with MS was 1. 88 times that of patients without MS complication〔95% CI(1. 06, 3. 85),P = 0. 031〕;after adjustment of gender,age and educational level,the risk of chronic complications in diabetic patients complicated with MS was 2. 24 times that of patients without MS〔95% CI(1. 24,4. 04),P = 0. 047〕. (3)Before intervention,diabetic with MS group was higher than diabetic group in BMI,waistline,hipline,waist _ hip ratio,neck circumference,SBP,DBP,FPG,2 hPG,HbA1c ,TG,LDL-C and blood uric acid( P < 0. 05);after intervention,BMI, waistline,hipline,waist _ hip ratio,neck circumference,FPG,2 hPG,HbA1c were higher than those of diabetic group(P <0. 05). Conclusion Diabetic patients complicated with MS are higher than diabetic patients without MS in the incidence of chronic complications,and the complication of MS increases the risk of cardiovascular and cerebrovascular diseases.
其他文献
临床资料 12例系1999年1月以来我科门诊及七台河市预防中心皮肤科患者,其中男4例,女8例,年龄16~55岁,平均35.8岁,病程3个月~8年,平均29.9月.10例患者治疗前用过各种口服、外用
我们对黄褐斑患者进行甲状腺功能检测,以探讨黄褐斑与甲状腺激素的关系,结果报告如下.rn材料和方法门诊黄褐斑患者37例,男10例,女27例,平均年龄31.5岁,对照组30例为无色素性
临床资料 96例均符合1994年全国中西医结合皮肤性病学会色素病学组标准[1],其中男51例,女45例,年龄8~58岁(平均35.6岁).病程1个月~11年,平均4年8个月.rn治疗方法所有病人均口服
患者男,69岁.2月前无诱因于右下腹部出现一约1.0cm×1.0cm圆形红斑,表面覆细小鳞屑,缓慢扩大,直径3.0cm×2.0cm,边缘稍突起,无自觉症状,未治疗.2周后躯干及四肢近端陆续出现
P1359澳大利亚1990-2007年脑炎的病因//Clare Huppatz,David N Durrheim, Christopher Levi,等rn脑炎是一种临床常见的综合征,由新兴的病原体引起,这些病原体在澳大利亚不在
例1,女,62岁。10年前发现腰骶部各生长一甲盖大小褐色斑,偶痒,皮损逐渐增大颜色加深,表面出现鳞屑。7年前左耳后、左胫前及腰部相继出现3处相似皮损。近年来皮损生长增快,且部分皮损有糜烂
患者,女,72岁,因腹痛、腹胀、呕吐,排便,排气停止24小时,加重2小时急诊入院。查体:一般状态可,急性面容,T 37.8℃,P 94次/分,BP 17/10kPa(130/80mmHg)。腹部膨隆,在中上腹可见肠型,未触
患者女,39岁,因颜面、下肢浮肿1年伴发热、光敏感、脱发、口腔溃疡及皮肤水疱7月入院。体检:颜面、下肢浮肿,面部蝶形红斑,全身皮肤粘膜散在大小不等水疱,疱壁薄,疱液清,尼氏征(+),口腔粘膜有
我科于1999年4月~10月应用派瑞松霜(西安杨森制药有限公司生产)治疗皮炎湿疹120例,现将结果报告如下.rn临床资料 120例均为门诊病人.男72例,女48例,平均年龄32岁(18~68岁);病程
我们自1999年3月~6月,用派瑞松霜(西安杨森制药有限公司生产)治疗皮炎、湿疹30例,现报告如下.rn临床资料随机选择门诊急性、亚急性、慢性皮炎湿疹患者30例,男11例,女19例;年龄